{
    "nct_id": "NCT04236479",
    "official_title": "Mesenchymal Stromal Cells Delivery Through Cardiopulmonary Bypass in Pediatric Cardiac Surgery",
    "inclusion_criteria": "* Neonatal and young infantile patients who are â‰¤ 3 months of age\n* Scheduled to undergo reparative two-ventricle repair for congenital heart defects without aortic arch reconstruction, including the following:\n\n  a. D-Transposition of the Great Arteries (d-TGA) Group: i. d-TGA with intact ventricular septum (d-TGA, IVS) ii. d-TGA with ventricular septal defect (d-TGA, VSD) b. Ventricular Septal Defect (VSD) Group: i. VSD without aortic arch obstruction (AAO) ii. Complete common atrioventricular canal defect (CAVC) c. Tetralogy of Fallot (TOF) Group: i. Tetralogy of Fallot (TOF) ii. Tetralogy of Fallot with Pulmonary Atresia (TOF,PA) iii. Truncus arteriosus (TA) iv. Double outlet right ventricle (DORV)\n* Scheduled surgery at or before three months of age.\n* Parent/guardian capable of providing informed consent.\nHealthy volunteers allowed\nMust have maximum age of 6 Months",
    "exclusion_criteria": "* Birth weight less than 2.0 kg\n* Recognizable phenotypic syndrome\n* Associated extracardiac anomalies of greater than minor severity\n* Previous cardiac surgery\n* Associated cardiovascular anomalies requiring aortic arch reconstruction and/or additional open cardiac surgical procedures in infancy\n* Prior severe hypoxic event\n* Significant screening test values that place subjects at increased risk of complications from participation in the study",
    "miscellaneous_criteria": ""
}